Q2 FY2025 · ended Sep 30, 2025 · Revenue $6.98M, +19.3% YoY · Filed Nov 10, 2025
Cyanotech Corp (CYAN) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In Q2 of fiscal 2025, the quarter ended Sep 30, 2025, it reported revenue of $7.0 million and net income of $1,000. As of Sep 30, 2025 it held $649,000 in cash and investments and $8.2 million in total debt.
Revenue
$6.98M
+19.3% vs year-ago quarter
Net income
$1,000
+100.1% vs year-ago quarter
Operating cash flow
$108,000
+124.3% vs year-ago quarter
Free cash flow
—
EPS
$0.00
+100.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
7.39M
+3.3% vs year-ago quarter
Net cash
$-7.59M
Q2 FY2025
Operating margin
-13.0%
TTM
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CYAN (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- Kailua Kona, HI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 768408
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2025 Sep 30, 2025 |
Q1 FY2025 Jun 30, 2025 |
Q3 FY2024 Dec 31, 2024 |
Q2 FY2024 Sep 30, 2024 |
Q1 FY2024 Jun 30, 2024 |
|---|---|---|---|---|---|
| Revenue | $7.0M | $5.8M | $6.2M | $5.8M | $5.9M |
| Operating income | $190,000 | -$753,000 | -$50,000 | -$975,000 | -$1.0M |
| Net income | $1,000 | -$926,000 | -$224,000 | -$1.1M | -$1.2M |
| Diluted EPS | $0.00 | — | — | -$0.16 | -$0.17 |
| Operating cash flow | $108,000 | -$328,000 | -$935,000 | -$444,000 | $243,000 |
| Total assets | $24.0M | $23.0M | $24.0M | $23.9M | $24.4M |
| Total liabilities | $16.0M | $15.0M | $14.5M | $14.2M | $13.8M |
| Stockholders' equity | $8.1M | $8.0M | $9.5M | $9.7M | $10.7M |
| Cash and investments | $649,000 | $383,000 | $359,000 | $780,000 | $720,000 |
| Total debt | $8.2M | $8.8M | $9.9M | $12.2M | $11.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 2, 2025 | Aug 29, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Aug 22, 2025 | Aug 21, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| ARS | Annual report to shareholders | Jul 10, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Jun 20, 2025 | Mar 31, 2025 |
All 870 Cyanotech Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.